Demand for protein A resin among other chromatography resins is considerably high. Increasing research on monoclonal antibodies (Mab) is expected to drive sales of protein A resin over the forecast period. Mab have been shown promising results in the treatment of chronic diseases such as cancers and rheumatoid arthritis, and increasing prevalence of these disease is expected to drive overall sales of protein A resin. Over the last few years, in order to offer better services, companies in the protein A resin market are manufacturing next generation protein A resin products to overcome conventional protein A resin issues such as ligand leaching and alkaline stability. Moreover, few companies are manufacturing cost-effective protein A resin products, especially for clinical research purposes. However, increasing awareness about alternate methods to purify monoclonal antibodies is expected to hamper sales of protein A resin during the forecast period.
Market Value Forecast
In terms of value, the global protein A resin market is anticipated to be valued at US$ 838.4 Mn by 2026, expanding at over 8% CAGR during the forecast period.
Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1720
Growing demand for biosimilars is one of the key factor expected to drive growth of the overall protein A resin market over the period 2016–2026. Globally moreover, major biopharmaceutical companies are increasing investments on the development of biosimilar products. This in turn is anticipated to fuel demand for protein A resin and drive overall growth of the global protein A resin market during the forecast period. In developed countries, governments are funding R&D of biologics including Mab. This in turn is expected to drive sales of protein A resin between 2016 and 2026. However, significantly high cost of protein A resin is one of the major factors restraining growth of the global protein A resin market.
Segmentation by Product
The global protein A resin market is segmented on the basis of product type into natural protein A resin and recombinant protein A resin. Among these segments, recombinant protein A resin segment is expected to expand at a highest CAGR exceeding 9% in revenue terms between 2016 and 2026.
Segmentation by Matrix Type
The global protein A resin market is segmented on the basis of matrix types into agarose-based matrix, glass or silica-based and organic polymer based type. Among the matrix type segments, agarose-based segment currently accounts for highest market share and the trend is expected to continue over the forecast period. Moreover, binding specificity and stability of agarose-based protein A resin is high when compared to other matrixes types. This factor is expected to contribute significantly to revenue growth the agarose-based protein A resin segment over the forecast period.
Segmentation by Application Type
The global protein A resin market is segmented on the basis of application type as immunoprecipitation and antibody purification. In the application segment, immunoprecipitation segment is expected to expand at a CAGR of around 9% in between 2016 and 2026.
Segmentation by End User
The global protein A resin market is segmented on the basis of end user into biopharmaceutical manufacturers, clinical research laboratories and academic institutes. Among the end user segments, biopharmaceutical manufacturers segment currently accounts for highest market share, and is expected to register a CAGR of 8% between 2016 and 2026.
Send An Enquiry@ http://www.futuremarketinsights.com/askus/rep-gb-1720
By region, the global protein A resin market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan, Middle East & Africa (MEA) and Japan.
Globally, in terms of revenue, North America has been estimated to account for highest share of 36.1% in 2016, followed by Western Europe. Meanwhile, revenue from the market in Asia Pacific excluding Japan (APEJ) is expected to expand at the highest CAGR of 9.3% over the forecast period.
Key players in the global protein A resin market include GE Healthcare, Thermo Fisher Scientific, Repligen Corporation, Tosoh Bioscience, EMD Millipore, Novasep, GenScript and Expedeon Ltd.
Companies in the global protein A resin market are entering into strategic agreements to manufacture raw material required for manufacturing of protein A resin.